- Home
- SER vs NTRB Comparison
SER vs NTRB Comparison
Compare SER & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- NTRB
- Stock Information
- Founded
- SER 2017
- NTRB 2016
- Country
- SER United States
- NTRB United States
- Employees
- SER N/A
- NTRB N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- SER Health Care
- NTRB Health Care
- Exchange
- SER Nasdaq
- NTRB Nasdaq
- Market Cap
- SER 45.2M
- NTRB 46.4M
- IPO Year
- SER 2018
- NTRB N/A
- Fundamental
- Price
- SER $4.81
- NTRB $4.11
- Analyst Decision
- SER
- NTRB
- Analyst Count
- SER 0
- NTRB 0
- Target Price
- SER N/A
- NTRB N/A
- AVG Volume (30 Days)
- SER 31.9K
- NTRB 26.3K
- Earning Date
- SER 11-12-2024
- NTRB 12-04-2024
- Dividend Yield
- SER N/A
- NTRB N/A
- EPS Growth
- SER N/A
- NTRB N/A
- EPS
- SER N/A
- NTRB N/A
- Revenue
- SER $3,157,500.00
- NTRB $2,021,771.00
- Revenue This Year
- SER N/A
- NTRB N/A
- Revenue Next Year
- SER N/A
- NTRB N/A
- P/E Ratio
- SER N/A
- NTRB N/A
- Revenue Growth
- SER 2454.55
- NTRB N/A
- 52 Week Low
- SER $3.81
- NTRB $2.22
- 52 Week High
- SER $19.93
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- SER 46.26
- NTRB 44.78
- Support Level
- SER $4.70
- NTRB $3.90
- Resistance Level
- SER $5.40
- NTRB $5.16
- Average True Range (ATR)
- SER 0.49
- NTRB 0.33
- MACD
- SER -0.01
- NTRB -0.01
- Stochastic Oscillator
- SER 11.93
- NTRB 27.04
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.